1.
Tralokinumab versus Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis with Hand Involvement: a Matching-Adjusted Indirect Comparison. J of Skin. 2026;10(2):s725. doi:10.25251/24g02225